Warby Parker Inc. has grown revenue 13% a year over three years and 13% a year over five. Revenue growth, 3-year annual rate: +13% (Medical Instruments & Supplies median +9.8%). Revenue growth, 5-year rate: +13%, growth has slowed since the five-year average. Years of annual history on file: 7, FY2019 to FY2025, as filed.

WRBYWarby Parker Inc.

Healthcare

$25.30-11% 1Y

$25.30

$16.4952 weeks$30.23

Latest close: back above its 200-day averageOct 9, 2026what changed →

Is it growing?

Mixed

Neither accelerating nor breaking down: revenue growing +11% year on year and operating margin widening (+2.4 points), but earnings down −200% year on year.

2 good, 1 to watch

Revenue trend+11% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings.

Earnings trend−200% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing slower than revenue, so the growth is costing something.

Margin direction+2.4 points operating

Trailing-twelve-month operating margin, 0.1% now against -2.3% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearsbetter than 76% of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is WRBY growing?

Warby Parker Inc. has grown revenue 13% a year over three years and 13% a year over five.

+13%

Revenue growth, 3-year annual rate · Medical Instruments & Supplies median +9.8% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +13%
Revenue growth, 5-year rate · +13% over three · growth has slowed since the five-year average
Years of annual history on file: 7
Years of annual history on file · FY2019 to FY2025, as filed

Details›